✦ LIBER ✦

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

✍ Scribed by Mark D Pegram, Virginia F Borges, Nuhad Ibrahim, Jyotsna Fuloria…

Book ID: 120699594
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 178 KB
Volume: 11
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr2409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study of the Anti-MUC-l Antibody

Phase I Study of the Anti-MUC-l Antibody, huHMFG1 (AS1402), in Patients with Advanced Breast Cancer

✍ Nigel Courtenay-Luck; Mark Pegram 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Dose escalation and pharmacokinetic stud

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

✍ Tokuda, Y; Watanabe, T; Omuro, Y; Ando, M; Katsumata, N; Okumura, A; Ohta, M; Fu 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

372 A phase I dose-escalation study of t

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase I dose escalation and pharmacokine

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

✍ Danson, S; Ferry, D; Alakhov, V; Margison, J; Kerr, D; Jowle, D; Brampton, M; Ha 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase II trial and pharmacokinetic asses

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer

✍ David C. Smith; Duncan I. Jodrell; Merrill J. Egorin; Roy M. Ambinder; Eleanor G 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 701 KB